Vascularized composite allografts and solid organ transplants: similarities and differences

Area of Science:

• Regenerative Medicine
• Transplantation Immunology
• Surgical Innovation

Background:

• Vascularized composite allotransplantation (VCA) offers improved form and function for complex tissue defects compared to conventional methods.
• Over 100 VCA cases reported in 13 years demonstrate its growing clinical application.
• VCA involves the transplantation of multiple tissue types, including skin, muscle, nerves, and bone.

Purpose of the Study:

• To summarize recent advancements in VCA over the past 12 months.
• To compare VCA developments with those in solid organ transplantation.
• To highlight new clinical immunosuppressive strategies and targets for VCA.

Main Methods:

• Review of recent publications on VCA.
• Analysis of clinical outcomes and immunological responses in VCA.
• Comparison of VCA immunosuppression protocols with solid organ transplantation.

Main Results:

• Improved understanding of topical immunosuppressants for VCA rejection prevention and treatment.
• Insights into mechanisms of chronic rejection in VCA.
• Successful minimization of immunosuppressive maintenance therapy via cell-based protocols in human upper-extremity transplantation.

Conclusions:

• Significant progress in VCA over the last year, particularly in immunosuppressive strategies.
• Identification of novel targets for immunosuppression and immunomodulation in VCA.
• Exploration of mesenchymal stem cell application for achieving transplant tolerance in VCA.